Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ: BMRN )

65.66 +0.66 (+1.02%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Other Filings

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Form S-3/A
Source: SEC/Edgar
December 25, 2001
Form 8-K
Source: SEC/Edgar
December 16, 2001
Form S-3MEF
Source: SEC/Edgar
December 06, 2001
Form 424B1
Source: SEC/Edgar
December 06, 2001
Form S-3/A
Source: SEC/Edgar
December 03, 2001
Form 8-K/A
Source: SEC/Edgar
November 14, 2001
Form S-3
Source: SEC/Edgar
November 08, 2001
Form S-3
Source: SEC/Edgar
November 05, 2001
Form 8-K
Source: SEC/Edgar
November 01, 2001
Form 8-K
Source: SEC/Edgar
November 01, 2001
Form 424B2
Source: SEC/Edgar
October 30, 2001
Form 8-K
Source: SEC/Edgar
October 25, 2001
Form 424B2
Source: SEC/Edgar
October 15, 2001
Form 8-K
Source: SEC/Edgar
October 09, 2001
Form 424B2
Source: SEC/Edgar
October 01, 2001
Form 8-K
Source: SEC/Edgar
September 10, 2001
Form 8-K
Source: SEC/Edgar
September 05, 2001
Form 424B2
Source: SEC/Edgar
August 22, 2001
Form 8-K
Source: SEC/Edgar
August 15, 2001
Form POS AM
Source: SEC/Edgar
August 15, 2001
Form 8-K
Source: SEC/Edgar
June 24, 2001
Form S-3/A
Source: SEC/Edgar
June 18, 2001
Form S-3
Source: SEC/Edgar
May 20, 2001
Form 8-K
Source: SEC/Edgar
May 17, 2001
Form DEFA14A
Source: SEC/Edgar
April 17, 2001
Form SC 13G
Source: SEC/Edgar
February 13, 2001
Form SC 13G/A
Source: SEC/Edgar
February 13, 2001
Form SC 13G/A
Source: SEC/Edgar
February 13, 2001
Form 424B2
Source: SEC/Edgar
January 30, 2001
Form S-3/A
Source: SEC/Edgar
January 28, 2001
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.